Eryaspase With Modified FOLFIRINOX in Advanced Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to FOLFIRINOX
Related studies linked through entity extraction aliases.
Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric Cancer
- Status
- RECRUITING
- Phase
- PHASE2
HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCC
- Status
- UNKNOWN
- Phase
- PHASE2
Pancreatic Locally Advanced Irresectable Cancer Ablation
- Status
- UNKNOWN
- Phase
- NA
Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Observational Retrospective Study of Evaluation of Prognostic Factors in Advanced Pancreatic Cancer Patients Treated With FOLFIRINOX
- Status
- COMPLETED
- Phase
- N/A
Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE3
Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE1
FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas
- Status
- TERMINATED
- Phase
- PHASE2
Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of FOLFIRINOX Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
First-line Metastatic Pancreatic Cancer : FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Phase II Study of Neoadjuvant FOLFIRINOX
- Status
- COMPLETED
- Phase
- PHASE2
Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2